Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study - Centre Jean Perrin Accéder directement au contenu
Article Dans Une Revue Cancer Medicine Année : 2018

Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study

Emmanuelle Bompas
  • Fonction : Auteur correspondant
  • PersonId : 1041487

Connectez-vous pour contacter l'auteur
Loïc Campion
Antoine Italiano
Axel Le Cesne
  • Fonction : Auteur
Olivier Mir
  • Fonction : Auteur
  • PersonId : 892590
Isabelle Ray-Coquard

Résumé

Five-year overall survival (OS) of localized RMS exceeds 70% in children (<18) but is very poor in adult patients. We analyzed the outcome and prognostic factors (PF) of a national series of adult patients with RMS in a large study. The study population consisted of two different cohorts: a retrospective cohort (157 adult patients treated in 13 reference centers between 05/1981 and 02/2010) and the prospective cohort (292 patients with RMS diagnosed and treated between 01/2010 and 12/2014 in France) included in the NetSarc database. A descriptive analysis of patients' characteristics and prognostic factors was conducted on both series which were compared. In the retrospective series, histological subtypes were embryonal (E-RMS) for 21% of patients, alveolar (A-RMS) for 35% of patients, and "adult-type" P-RMS (pleomorphic, spindle cell RMS, not otherwise specified) (P) for 44% patients. This distribution significantly differed in the prospective cohort: A-RMS: 18%; E-RMS: 17%; and P-RMS 65%. With a median follow-up of 8.5 years, 5-year OS for localized RMS and advanced RMS (with nodes and/or metastases) was 43% and 5%, respectively, (P < 0.0001), and median OS was 51, 33, and 16 months for E-RMS, A-RMS, and P-RMS, respectively, in the retrospective cohort. The median OS was less than 40 months for the prospective nationwide cohort for the entire population. In a multivariate analysis of the retrospective study, independent prognostic factors for OS were A-RMS, R0 resection, and adjuvant radiotherapy (RT). For localized RMS, age and use of pediatric chemotherapy (CT) regimen are independent prognostic factors. Adult patients with RMS have a poorer overall survival than pediatric patients, and survival varies considerably across histological subtypes.
Fichier principal
Vignette du fichier
Outcome of 449 adult patients.pdf (297.5 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-01978221 , version 1 (28-05-2020)

Licence

Identifiants

Citer

Emmanuelle Bompas, Loïc Campion, Antoine Italiano, Axel Le Cesne, Christine Chevreau, et al.. Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study. Cancer Medicine, 2018, Cancer medicine, 7 (8), pp.4023-4035. ⟨10.1002/cam4.1374⟩. ⟨hal-01978221⟩
285 Consultations
85 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More